Status:
COMPLETED
Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Covid-19
Eligibility:
All Genders
18+ years
Brief Summary
Describes the cohort of patients receiving ECMO-VV or ECMO-VA in the management of severe ARDS refractory to SARS-CoV-2 in the Strasbourg and Louvain centres
Eligibility Criteria
Inclusion
- Patient over the age of 18;
- Diagnostic COVID-19 by RT-PCR;
- Hospitalisation in resuscitation for the management of complications related to COVID-19
- Implanted ECMO-VV or VA during hospitalisation;
- Patient agreeing to participate in the study
Exclusion
- Sujet who has expressed opposition to participating in the study.
- Sujet under guardianship or trusteeship
- Sujet under safeguard of justice
Key Trial Info
Start Date :
June 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 18 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04446286
Start Date
June 18 2020
End Date
August 18 2020
Last Update
October 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Chirurgie Thoracique Nouvel Hôpital Civil Hôpitaux Universitaires de Strasbourg
Strasbourg, France, 67091